Ibu-Lysin - 1 A Pharma (Ibuprofen)

Ibuprofen works by reversibly blocking the cyclooxygenase enzymes COX‑1 and COX‑2, which are essential for converting arachidonic acid into prostaglandins. Prostaglandins mediate pain, fever, and inflammation, so their reduced production leads to analgesic, antipyretic, and anti‑inflammatory effects throughout the body.

The appropriate dose of Ibu-Lysin is determined by a qualified prescriber based on the patient’s age, weight, medical condition, and response to therapy. Healthcare professionals consider factors such as severity of symptoms, renal and hepatic function, and potential drug interactions before recommending a specific dosing regimen.

Safety of ibuprofen during pregnancy and lactation depends on the trimester and individual risk factors. Generally, ibuprofen is avoided in the third trimester because of potential fetal cardiovascular effects. During breastfeeding, small amounts may pass into milk, so a healthcare provider should evaluate the risk‑benefit ratio before use.

To order Ibu-Lysin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details and any necessary import documentation.

Ibu-Lysin (ibuprofen) shares the core anti‑inflammatory and analgesic properties of the NSAID class, but its potency, half‑life, and gastrointestinal safety profile differ from agents such as naproxen or diclofenac. Ibuprofen has a relatively short half‑life, allowing flexible dosing, and is often preferred for short‑term pain and fever management.

Ibu-Lysin should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Ibu-Lysin is taken orally, usually with a full glass of water. It may be taken with or without food; however, taking it with food can reduce the likelihood of stomach irritation. The exact administration schedule is determined by the prescribing clinician.

Serious risks include gastrointestinal bleeding or ulceration, especially with prolonged use or in patients with a history of ulcers. Renal impairment can occur, particularly in individuals with pre‑existing kidney disease or dehydration. Rarely, severe allergic reactions such as anaphylaxis may develop, requiring immediate medical attention.

Ibu-Lysin should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal bleeding, severe heart failure, or advanced renal or hepatic impairment. It is also contraindicated in patients who have had recent coronary artery bypass graft surgery or who are taking certain anticoagulants without medical supervision.